Cargando…

Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML

The key myeloid transcription factor (TF), CEBPA, is frequently mutated in acute myeloid leukemia (AML), but the direct molecular effects of this leukemic driver mutation remain elusive. To investigate CEBPA mutant AML, we performed microscale, in vivo chromatin immunoprecipitation sequencing and id...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jakobsen, Janus S., Laursen, Linea G., Schuster, Mikkel B., Pundhir, Sachin, Schoof, Erwin, Ge, Ying, d’Altri, Teresa, Vitting-Seerup, Kristoffer, Rapin, Nicolas, Gentil, Coline, Jendholm, Johan, Theilgaard-Mönch, Kim, Reckzeh, Kristian, Bullinger, Lars, Döhner, Konstanze, Hokland, Peter, Fitzgibbon, Jude, Porse, Bo T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620102/ https://www.ncbi.nlm.nih.gov/pubmed/31309149 http://dx.doi.org/10.1126/sciadv.aaw4304

Ejemplares similares

The ASXL1-G643Wvariant accelerates the development of CEBPA mutant acute myeloid leukemia
por: D’Altri, Teresa, et al.
Publicado: (2020)

TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression
por: Heyes, Elizabeth, et al.
Publicado: (2023)

P1413: TRANSCRIPTION FACTOR-DRIVEN COORDINATION OF CELL CYCLE EXIT AND SPECIFICATION OF CELL IDENTITY IN VIVO DURING GRANULOCYTIC DIFFERENTIATION - IN MEMORIAM PROF. NIELS BORREGAARD
por: Theilgaard-Mönch, K., et al.
Publicado: (2022)

Transcription factor-driven coordination of cell cycle exit and lineage-specification in vivo during granulocytic differentiation: In memoriam Professor Niels Borregaard
por: Theilgaard-Mönch, Kim, et al.
Publicado: (2022)

HemaExplorer: a database of mRNA expression profiles in normal and malignant haematopoiesis
por: Bagger, Frederik Otzen, et al.
Publicado: (2013)

spliceR: an R package for classification of alternative splicing and prediction of coding potential from RNA-seq data
por: Vitting-Seerup, Kristoffer, et al.
Publicado: (2014)

Most protein domains exist as variants with distinct functions across cells, tissues and diseases
por: Vitting-Seerup, Kristoffer
Publicado: (2023)

BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis
por: Bagger, Frederik Otzen, et al.
Publicado: (2016)

UPF2-Dependent Nonsense-Mediated mRNA Decay Pathway Is Essential for Spermatogenesis by Selectively Eliminating Longer 3'UTR Transcripts
por: Bao, Jianqiang, et al.
Publicado: (2016)

Targeting of PI3K/AKT signaling and DNA damage response in acute myeloid leukemia: a novel therapeutic strategy to boost chemotherapy response and overcome resistance
por: Estruch, Montserrat, et al.
Publicado: (2021)

Editorial: Alternative Splicing in Health and Disease
por: Kahraman, Abdullah, et al.
Publicado: (2022)

ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiation
por: Knudsen, Kasper Jermiin, et al.
Publicado: (2015)

Amplification of pico-scale DNA mediated by bacterial carrier DNA for small-cell-number transcription factor ChIP-seq
por: Jakobsen, Janus S, et al.
Publicado: (2015)

Temporal mapping of CEBPA and CEBPB binding during liver regeneration reveals dynamic occupancy and specific regulatory codes for homeostatic and cell cycle gene batteries
por: Jakobsen, Janus Schou, et al.
Publicado: (2013)

Quantitative single-cell proteomics as a tool to characterize cellular hierarchies
por: Schoof, Erwin M., et al.
Publicado: (2021)

Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapy
por: Bogetofte Barnkob, Mike, et al.
Publicado: (2022)

Expression and splicing mediate distinct biological signals
por: Dam, Søren Helweg, et al.
Publicado: (2023)

P1403: ENDOMUCIN IS A MARKER OF QUIESCENT HAEMATOPOIETIC STEM CELLS WITH HIGH LONG-TERM ENGRAFTMENT CAPACITY
por: Engelhard, S., et al.
Publicado: (2022)

Progression of the pluripotent epiblast depends upon the NMD factor UPF2
por: Chousal, Jennifer N., et al.
Publicado: (2022)

Peak-valley-peak pattern of histone modifications delineates active regulatory elements and their directionality
por: Pundhir, Sachin, et al.
Publicado: (2016)

CAGEfightR: analysis of 5′-end data using R/Bioconductor
por: Thodberg, Malte, et al.
Publicado: (2019)

satuRn: Scalable analysis of differential transcript usage for bulk and single-cell RNA-sequencing applications
por: Gilis, Jeroen, et al.
Publicado: (2022)

The HOPX and BLBP landscape and gliogenic regions in developing human brain
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2023)

CCAAT enhancer binding protein alpha (CEBPA) biallelic acute myeloid leukaemia: cooperating lesions, molecular mechanisms and clinical relevance
por: Wilhelmson, Anna S., et al.
Publicado: (2020)

Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
por: Pabst, T, et al.
Publicado: (2009)

Initiation of MLL-rearranged AML is dependent on C/EBPα
por: Ohlsson, Ewa, et al.
Publicado: (2014)

Reply to ‘Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis’
por: Hou, H-A, et al.
Publicado: (2009)

Phosphorylation of Serine 248 of C/EBPα Is Dispensable for Myelopoiesis but Its Disruption Leads to a Low Penetrant Myeloid Disorder with Long Latency
por: Hasemann, Marie S., et al.
Publicado: (2012)

From Laser Scanning to Finite Element Analysis of Complex Buildings by Using a Semi-Automatic Procedure
por: Castellazzi, Giovanni, et al.
Publicado: (2015)

Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis
por: Quintana-Bustamante, Oscar, et al.
Publicado: (2012)

Loss of C/EBPα cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage
por: Porse, Bo T., et al.
Publicado: (2005)

Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
por: Pfeiffer, Anamarija, et al.
Publicado: (2022)

The splicing factor RBM25 controls MYC activity in acute myeloid leukemia
por: Ge, Ying, et al.
Publicado: (2019)

Hematopoietic stem cell development requires transient Wnt/β-catenin activity
por: Ruiz-Herguido, Cristina, et al.
Publicado: (2012)

Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2021)

Oncogenic fusion proteins expressed in immature hematopoietic cells fail to recapitulate the transcriptional changes observed in human AML
por: Rapin, N, et al.
Publicado: (2014)

The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes
por: Trempenau, Mette Louise, et al.
Publicado: (2023)

Germline CEBPA mutation in familial acute myeloid leukemia
por: Boada, Matilde, et al.
Publicado: (2021)

Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
por: Yuan, Ji, et al.
Publicado: (2023)

getITD for FLT3-ITD-based MRD monitoring in AML
por: Blätte, Tamara J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sq85a9civth36l22bt2flib2qe